FDA: For Niaspan Reduced Flushing Claim, Pre-Defined Criteria Necessary
This article was originally published in The Pink Sheet Daily
Executive Summary
Abbott would also need a “good-sized study” to support such a claim, CDER Metabolism and Endocrinology Products Deputy Director Colman tells “The Pink Sheet” DAILY.